Boston Scientific has launched the Promus Element Plus BTK (Below The Knee) everolimus-eluting stent system in European countries for the treatment of certain severe peripheral artery lesions. The drug-eluting stent (DES) has CE mark approval for both monorail and over-the-wire (OTW) versions and will be available immediately.

The average age of installed magnetic resonance imaging (MRI) scanners in the United States has increased from eight years in 2007 to 10.9 years in 2011, according to a new market research report by IMV Medical Information Division.

The American College of Cardiology (ACC) has certified Lumedx software as fully interoperable between four ACC NCDR registries. Lumedx, a leading provider of integrated cardiovascular imaging and information systems, is currently the only software vendor offering this level of interoperability.

Eizo Nanao Technologies Inc. announced they will unveil the RadiForce RX440, a new 4 MP (2,560 x 1,600 native resolution) color LCD monitor, and the GX540, a 5 MP (2,048 x 2,560 native resolution) monochrome LCD, at the 2012 meeting of the Radiological Society of North America (RSNA).

Abbott bioresorbable Absorb stent BVS
Abbott bioresorbable Absorb stent BVS
Abbott bioresorbable Absorb stent BVS
Abbott bioresorbable Absorb stent BVS

Abbott Vascular began its international launch of the Absorb coronary stent, the world's first drug-eluting bioresorbable vascular scaffold (BVS). It is now widely available across Europe and parts of Asia Pacific and Latin America. The Absorb is a first-of-its-kind device for the treatment of coronary artery disease (CAD).

September 25, 2012 — Patients are often aggressively treated with anticoagulants, or blood thinners, to help prevent pulmonary emboli from forming, but a study published in the September 2012 issue of the Journal of the American Academy of Orthopaedic Surgeons indicates that some blood clots being identified by today's sensitive testing methods may not require aggressive treatments.


Sept. 25, 2012 — America's healthcare system has become too complex and costly to continue business as usual, says a new report from the Institute of Medicine. Inefficiencies, an overwhelming amount of data and other economic and quality barriers hinder progress in improving health and threaten the nation's economic stability and global competitiveness, the report says. However, the knowledge and tools exist to put the health system on the right course to achieve continuous improvement and better quality care at lower cost, added the committee that wrote the report.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now